|15.13||+0.36 / +2.44%|
Data as of 4:00pm ET
|14.96||-0.1694 / -1.12%|
The 5 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 22.00, with a high estimate of 25.00 and a low estimate of 16.00. The median estimate represents a +45.41% increase from the last price of 15.13.
The current consensus among 5 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.